Antidepressant-like effect of sodium butyrate (HDAC inhibitor) and its molecular mechanism of action in the rat hippocampus

aan het Rot M, 2009, Mt Sinai J Med, 76, 204, 10.1002/msj.20094

Baltus GA, 2009, J Biol Chem, 284, 6998, 10.1074/jbc.M807670200

Berton O, 2006, Nat Rev Neurosci, 7, 137, 10.1038/nrn1846

Boffa LC, 1978, J Biol Chem, 253, 3364, 10.1016/S0021-9258(17)34804-4

Canitano A, 2002, Ann NY Acad Sci, 976, 394, 10.1111/j.1749-6632.2002.tb04766.x

Celada P, 2004, J Psychiatry Neurosci, 29, 252

Davis PJ, 1970, Endocrinology, 87, 978, 10.1210/endo-87-5-978

De Luca V, 2007, Eur Psychiatry, 22, 282, 10.1016/j.eurpsy.2006.12.001

Dokmanovic M, 2005, J Cell Biochem, 96, 293, 10.1002/jcb.20532

Duman RS, 2006, Biol Psychiatry, 59, 1116, 10.1016/j.biopsych.2006.02.013

Fekadu A, 2009, J Affect Disord, 116, 4, 10.1016/j.jad.2008.10.014

Ferrante RJ, 2003, J Neurosci, 23, 9418, 10.1523/JNEUROSCI.23-28-09418.2003

Fuchikami M, 2009, Int J Neuropsychopharmacol, 12, 73, 10.1017/S1461145708008997

Fung WP, 1988, J Biol Chem, 263, 480, 10.1016/S0021-9258(19)57418-X

Gabellini N, 2004, Mol Neurobiol, 30, 91, 10.1385/MN:30:1:091

Gomez E, 2001, Actas Esp Psiquiatr, 29, 186

Gray JA, 2001, Brain Res Bull, 56, 441, 10.1016/S0361-9230(01)00623-2

Gregus A, 2005, Behav Brain Res, 156, 105, 10.1016/j.bbr.2004.05.013

Gundersen BB, 2009, Neuropharmacology, 57, 67, 10.1016/j.neuropharm.2009.04.008

Hagen GA, 1973, J Clin Endocrinol Metab, 37, 415, 10.1210/jcem-37-3-415

Jin K, 2001, J Mol Neurosci, 16, 49, 10.1385/JMN:16:1:49

Kadota K, 2008, Algorithms Mol Biol, 3, 8, 10.1186/1748-7188-3-8

Kim HJ, 2007, J Pharmacol Exp Ther, 321, 892, 10.1124/jpet.107.120188

Kim HJ, 2009, J Neurochem, 110, 1226, 10.1111/j.1471-4159.2009.06212.x

Kohda K, 2006, Int J Neuro psychopharmacol, 9, 201

Kramer OH, 2001, Trends Endocrinol Metab, 12, 294, 10.1016/S1043-2760(01)00438-6

Little A, 2009, Am Fam Physician, 80, 167

Marks PA, 2000, J Natl Cancer Inst, 92, 1210, 10.1093/jnci/92.15.1210

Marks W, 2009, Physiol Behav, 98, 67, 10.1016/j.physbeh.2009.04.014

Mathew SJ, 2008, Depress Anxiety, 25, 989, 10.1002/da.20540

Minamiyama M, 2004, Hum Mol Genet, 13, 1183, 10.1093/hmg/ddh131

Mintun MA, 2004, Biol Psychiatry, 55, 217, 10.1016/j.biopsych.2003.08.015

Nucifora FC, 2001, Science, 291, 2423, 10.1126/science.1056784

10.1128/MCB.23.12.4162-4173.2003

Rouaux C, 2003, EMBO J, 22, 6537, 10.1093/emboj/cdg615

Saha RN, 2006, Cell Death Differ, 13, 539, 10.1038/sj.cdd.4401769

Schramm NL, 2001, J Neurosci, 21, 4875, 10.1523/JNEUROSCI.21-13-04875.2001

Schreiber G, 2002, Clin Chem Lab Med, 40, 1200, 10.1515/CCLM.2002.210

Schroeder FA, 2007, Biol Psychiatry, 62, 55, 10.1016/j.biopsych.2006.06.036

Schroeder FA, 2008, Neuropsychopharmacology, 33, 2981, 10.1038/npp.2008.15

Sheline YI, 2004, Neuropsychopharmacology, 29, 2235, 10.1038/sj.npp.1300555

Steru L, 1985, Psychopharmacology (Berlin), 85, 367, 10.1007/BF00428203

Sullivan GM, 2006, Biol Psychiatry, 60, 500, 10.1016/j.biopsych.2005.11.022

Tsankova NM, 2006, Nat Neurosci, 9, 519, 10.1038/nn1659

Tsankova N, 2007, Nat Rev Neurosci, 8, 355, 10.1038/nrn2132

Uittenbogaard M, 2002, Brain Res Gene Expr Patterns, 1, 115, 10.1016/S1567-133X(01)00022-9

Umathe SN, 2008, Neuropeptides, 42, 399, 10.1016/j.npep.2008.04.005

Van Lint C, 1996, Gene Expr, 5, 245

10.1038/sj.onc.1207654

Xu WS, 2007, Oncogene, 26, 5541, 10.1038/sj.onc.1210620

Xu Z, 2009, Eur Neuropsycho pharmacol, 19, 868, 10.1016/j.euroneuro.2009.07.004

Ying M, 2006, J Biol Chem, 281, 12580, 10.1074/jbc.M511677200